Home Medicine The effects of dry ice exposure on plasma pH and coagulation analyses
Article
Licensed
Unlicensed Requires Authentication

The effects of dry ice exposure on plasma pH and coagulation analyses

  • Lene Trondsetås , Gustav Mikkelsen and Ingrid Alsos Lian EMAIL logo
Published/Copyright: August 28, 2017

Abstract

Background:

We recently observed that exposure to dry ice lowered sample pH and increased clotting times in lupus anticoagulant analyses, and that such changes could be prevented by placing samples at −80°C after dry ice exposure. In the current study, we sought to evaluate the effects of dry ice exposure on pH and various commonly used coagulation analyses.

Methods:

Citrated plasma from 30 healthy blood donors was allocated to four preanalytical regimes: (1) immediate analysis of fresh plasma or (2) storage at −20°C; (3) storage at −20°C followed by dry ice exposure for 24 h or (4) storage at −20°C followed by dry ice exposure for 24 h and storage at −80°C for 24 h before analysis. Analyses of pH, prothrombin time international normalized ratio (PT-INR), activated partial thromboplastin time (APTT), antithrombin, fibrinogen, protein C and protein S was performed.

Results:

Samples exposed to dry ice had significantly lower pH, prolonged clotting times in PT-INR, APTT and fibrinogen analyses as well as lower levels of protein C, than samples not exposed to dry ice. These changes in coagulation analyses were not present if samples were stored at −80°C for 24 h after dry ice exposure. Antithrombin and protein S were not significantly affected by dry ice exposure.

Conclusions:

Dry ice exposure lowered sample pH and affected various coagulation analyses. These effects were avoided by storing samples at −80°C for 24 h after dry ice exposure.


Corresponding author: Ingrid Alsos Lian, MD, PhD, Department of Clinical Chemistry, St. Olavs Hospital, 7006 Trondheim, Norway, Phone: +47 959 29619, Fax: +47 725 76 420

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline – Fifth Edition. CLSI document H21-A5 (ISBN 1-56238-657-3). Wayne, PA: CLSI, 2008.Search in Google Scholar

2. Murphy BM, Swarts S, Mueller BM, van der Geer P, Manning MC, Fitchmun MI. Protein instability following transport or storage on dry ice. Nat Methods 2013;10:278–9.10.1038/nmeth.2409Search in Google Scholar

3. Clinical and Laboratory Standards Institute (CLSI). Laboratory testing for the lupus anticoagulant; Approved guideline. CLSI document H60-1 (ISBN 1-56238-960-2). Wayne, PA: CLSI, 2014.Search in Google Scholar

4. Odsaeter IH, Lian IA, Bratberg K, Mikkelsen G. Dry ice exposure of plasma samples influences pH and lupus anticoagulant analysis. Clin Chem Lab Med 2015;53:809–13.10.1515/cclm-2014-0639Search in Google Scholar

5. Siggaard-Andersen O. The acid-base status of the blood. Scand J Clin Lab Invest 1963;15(Suppl 70):1–134.Search in Google Scholar

6. Plumhoff EA, Fisher PK, Bowie EJ, Nichols WL. Reversible prothrombin time prolongation after plasma storage on dry ice. Thromb Haemost 1992;68:232.10.1055/s-0038-1659822Search in Google Scholar

7. Vis R, van den Besselaar AM, Witteveen E, Meeuwisse-Braun J, Schaefer-van Mansfeld H. Artificial prolongation of the prothrombin time of lyophilized plasma induced by transportation with solid carbon dioxide. Thromb Haemost 1992;67:725.10.1055/s-0038-1648531Search in Google Scholar

8. Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effects of storage and thawing conditions on coagulation testing. Int J Lab Hematol 2015;37:551–9.10.1111/ijlh.12342Search in Google Scholar

9. Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg 1978;136:257–9.10.1016/0002-9610(78)90241-6Search in Google Scholar

10. Okude M, Yamanaka A, Akihama S. The effects of pH on the generation of turbidity and elasticity associated with fibrinogen-fibrin conversion by thrombin are remarkably influenced by sialic acid in fibrinogen. Biol Pharm Bull 1995;18:203–7.10.1248/bpb.18.203Search in Google Scholar PubMed

Received: 2017-3-27
Accepted: 2017-5-26
Published Online: 2017-8-28
Published in Print: 2017-11-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Method comparison – a practical approach based on error identification
  4. Review
  5. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease
  6. Mini Reviews
  7. α-Defensin point-of-care test for diagnosis of prosthetic joint infections: neglected role of laboratory and clinical pathologists
  8. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature
  9. Opinion Paper
  10. New issues on measurement of B-type natriuretic peptides
  11. Genetics and Molecular Diagnostics
  12. The SEeMORE strategy: single-tube electrophoresis analysis-based genotyping to detect monogenic diseases rapidly and effectively from conception until birth
  13. General Clinical Chemistry and Laboratory Medicine
  14. Determination of serum calcium levels by 42Ca isotope dilution inductively coupled plasma mass spectrometry
  15. The effects of dry ice exposure on plasma pH and coagulation analyses
  16. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia
  17. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy
  18. Performance analysis of automated evaluation of Crithidia luciliae-based indirect immunofluorescence tests in a routine setting – strengths and weaknesses
  19. Performance of automated digital cell imaging analyzer Sysmex DI-60
  20. Reference Values and Biological Variations
  21. Determination of reference intervals for urinary steroid profiling using a newly validated GC-MS/MS method
  22. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy
  23. Definition of the upper reference limit of glycated albumin in blood donors from Italy
  24. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents
  25. Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose
  26. Cancer Diagnostics
  27. Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers
  28. Cardiovascular Diseases
  29. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis
  30. Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay
  31. Infectious Diseases
  32. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor
  33. Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis
  34. Acknowledgment
  35. Letters to the Editor
  36. Handling the altered test results of hemolyzed samples. Recommendations of the Quality, Management, Safety and Evidence Committee (CCGSE) of the Spanish Association of Medical Biopathology and Laboratory Medicine (AEBM-ML)
  37. Reply to: Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor
  38. Excessive hypercortisolemia due to ectopic Cushing’s syndrome requiring extending the reportable range for plasma cortisol for management
  39. Heavy chain disease: our experience
  40. An abnormal elevation of serum CA72-4 due to taking colchicine
  41. Rivaroxaban non-responders: do plasma measurements have a place?
  42. Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma
  43. A multicenter effort to improve comparability of vitamin B6 assays in whole blood
  44. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis
Downloaded on 14.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0263/html
Scroll to top button